To evaluate if LC-SPIK can be an equally effective biomarker in patients with non-viral cirrhosis, LC-SPIK levels in both viral and non-viral cirrhosis patients were evaluated and LC-SPIK and AFP performance was evaluated to detect HCC in viral cirrhosis. Here, AFP is linked to hepatocellular carcinoma.